CVP Analysis and Strategy for Clipboard Tablet X5, X6, X7
This paper analyzes the financial performance of Clipboard Tablet's three product lines — X5, X6, and X7 — using Cost-Volume-Profit (CVP) methodology across the 2012–2015 fiscal years. The analysis examines contribution margins, break-even points (in both revenue and unit terms), and margins of safety for each tablet. Based on these findings, the paper develops a revised four-year strategy addressing product pricing, research and development allocation percentages, and potential product discontinuations. Key recommendations include reducing the price of the X7 tablet to stimulate demand, gradually discontinuing the X5 and X6 lines as their contribution margins decline, and increasing R&D investment in the X7 to reduce variable costs and enhance market competitiveness.
- Introduction: Scope and purpose of the CVP analysis
- Preceding Analysis and Revenue Overview: Baseline prices, revenue, and profit data
- Cost-Volume-Profit Analysis Framework: CVP methodology, assumptions, and key components
- CVP Models by Year (2012–2015): Annual cost models with margins and break-even figures
- Strategic Recommendations: Pricing, R&D, and discontinuation recommendations per product
- Results and Conclusion: Summary of findings and final strategic direction
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Integrates quantitative financial tables directly with qualitative strategic interpretation, allowing the reader to follow the reasoning from raw data to recommendation.
- Applies CVP assumptions explicitly before conducting the analysis, demonstrating methodological transparency and academic rigor.
- Tracks each product across four consecutive fiscal years, enabling trend-based reasoning rather than single-year snapshots.
Key academic technique demonstrated
The paper demonstrates applied CVP analysis — a core managerial accounting technique — by calculating contribution margins, break-even revenue, and margin of safety for three distinct product lines. It then connects those metrics to concrete strategic decisions (price reduction, R&D reallocation, and product discontinuation), showing how quantitative models can directly inform business strategy.
Structure breakdown
The paper opens with a brief introduction identifying its analytical scope. It then presents baseline revenue and profit data from the prior SLP analysis before explaining the CVP framework and its underlying assumptions. The bulk of the paper consists of four annual cost models (2012–2015) presented in tabular form. A strategic analysis section interprets trends for each product, followed by a conclusion that synthesizes the recommended four-year plan. This structure moves logically from data to framework to findings to strategy.
Introduction
This paper analyzes Clipboard Tablet (CT) performance and provides a revised strategy for the four-year plan that was initially developed. The analysis is based on Cost-Volume-Profit (CVP) analysis. The revised strategy takes into account prices, research and development allocation percentages, and any rational product discontinuations for the X5, X6, and X7 tablets for each of the years ranging from 2012 to 2015. The analysis considers the break-even point of each product in the financial years, both in terms of revenue generated and sales units. In addition, the analysis outlines the contribution margin for the tablets in the 2012, 2013, 2014, and 2015 financial years, as well as the margin of safety.
Preceding Analysis and Revenue Overview
The set product prices of the three individual tablets, together with the research and development percentage allocation, are illustrated below:
Tablet | Set Product Price | R&D Allocation
X5 | $285.00 | 33%
X6 | $430.00 | 34%
X7 | $190.00 | 33%
Based on market rates, X5 has a market price of $285, X6 has a market price of $430, and X7 has a market price of $190.
Revenue ($)
X5: 2011 — $276,159,075 | 2012 — $469,563,809 | 2013 — $611,502,211 | 2014 — $528,155,442 | 2015 — $274,676,048
X6: 2011 — $243,073,200 | 2012 — $554,269,513 | 2013 — $918,020,206 | 2014 — $1,016,546,240 | 2015 — $480,801,048
X7: 2011 — $0 | 2012 — $31,461,253 | 2013 — $45,068,365 | 2014 — $64,305,057 | 2015 — $91,167,056
Total Profit ($)
X5: 2011 — $43,991,298 | 2012 — $139,504,962 | 2013 — $206,738,942 | 2014 — $167,258,894 | 2015 — $47,189,707
X6: 2011 — $37,579,840 | 2012 — $154,134,825 | 2013 — $285,254,260 | 2014 — $320,769,459 | 2015 — $127,652,006
X7: 2011 — $0 | 2012 — ($23,065,952) | 2013 — ($13,397,740) | 2014 — $270,435 | 2015 — $19,356,593
Create your account
Always verify citation format against your institution’s current style guide requirements.